260 related articles for article (PubMed ID: 25818425)
1. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
2. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
4. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
5. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
[TBL] [Abstract][Full Text] [Related]
7. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
8. Efficient and High-Speed Transduction of an Antibody into Living Cells Using a Multifunctional Nanocarrier System to Control Intracellular Trafficking.
Yamada Y; Perez SM; Tabata M; Abe J; Yasuzaki Y; Harashima H
J Pharm Sci; 2015 Sep; 104(9):2845-54. PubMed ID: 25546552
[TBL] [Abstract][Full Text] [Related]
9. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
11. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
[TBL] [Abstract][Full Text] [Related]
12. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
Ishitsuka T; Akita H; Harashima H
J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
[TBL] [Abstract][Full Text] [Related]
13. An approach to transgene expression in liver endothelial cells using a liposome-based gene vector coated with hyaluronic acid.
Yamada Y; Hashida M; Hayashi Y; Tabata M; Hyodo M; Ara MN; Ohga N; Hida K; Harashima H
J Pharm Sci; 2013 Sep; 102(9):3119-27. PubMed ID: 23471825
[TBL] [Abstract][Full Text] [Related]
14. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Kogure K
Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
[TBL] [Abstract][Full Text] [Related]
15. An efficient PEGylated gene delivery system with improved targeting: Synergism between octaarginine and a fusogenic peptide.
Khalil IA; Harashima H
Int J Pharm; 2018 Mar; 538(1-2):179-187. PubMed ID: 29341911
[TBL] [Abstract][Full Text] [Related]
16. Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2011 Jan; 149(1):58-64. PubMed ID: 20826039
[TBL] [Abstract][Full Text] [Related]
17. A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.
Mudhakir D; Akita H; Tan E; Harashima H
J Control Release; 2008 Jan; 125(2):164-73. PubMed ID: 18054812
[TBL] [Abstract][Full Text] [Related]
18. [Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
Kogure K; Akita H; Harashima H
Yakugaku Zasshi; 2008 Feb; 128(2):219-32. PubMed ID: 18239369
[TBL] [Abstract][Full Text] [Related]
19. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression.
Khalil IA; Kogure K; Futaki S; Harashima H
J Biol Chem; 2006 Feb; 281(6):3544-51. PubMed ID: 16326716
[TBL] [Abstract][Full Text] [Related]
20. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]